{Reference Type}: Letter
{Title}: Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.
{Author}: Niyomnaitham S;Toh ZQ;Licciardi PV;Wongprompitak P;Srisutthisamphan K;Copeland KK;Chokephaibulkit K;Niyomnaitham S;Toh ZQ;Licciardi PV;Wongprompitak P;Srisutthisamphan K;Copeland KK;Chokephaibulkit K;
{Journal}: J Infect
{Volume}: 85
{Issue}: 4
{Year}: Oct 2022
{Factor}: 38.637
{DOI}: 10.1016/j.jinf.2022.06.014
{Abstract}: